Author:
Sader Helio S.,Flamm Robert K.,Jones Ronald N.
Abstract
ABSTRACTCeftaroline-avibactam and comparator agents were tested by the broth microdilution method against 20,089 isolates consecutively collected in 2010 and 2011 from 75 U.S. medical centers. Ceftaroline-avibactam was active againstEnterobacteriaceae(4,908 strains; MIC90, 0.25 μg/ml; highest MIC, 4 μg/ml), including meropenem-nonsusceptibleKlebsiellaspp. and ceftazidime-nonsusceptibleEnterobacter cloacaestrains (MIC90, 1 μg/ml for both). Ceftaroline-avibactam was also active against ceftriaxone-nonsusceptibleStreptococcus pneumoniae(MIC90, 0.25 μg/ml) and methicillin-resistantStaphylococcus aureus(MIC90, 1 μg/ml).
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference14 articles.
1. Summary of ceftaroline fosamil clinical trial studies and clinical safety Clin;File;Infect. Dis.,2012
2. Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program;Flamm;Antimicrob. Agents Chemother.,2012
3. Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more beta-lactamases and methicillin-resistant Staphylococcus aureus carrying various SCCmec types;Castanheira;Antimicrob. Agents Chemother.,2012
4. AstraZenecaAB. 2012. Zinforo package insert. AstraZeneca AB, Södertälje, Sweden. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002252/WC500132586.pdf. Accessed December 2012.
5. Avibactam is a covalent, reversible, non-beta-lactam beta-lactamase inhibitor;Ehmann;Proc. Natl. Acad. Sci. U. S. A.,2012
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献